Quick Verdict (TL;DR)
What is being evaluated: Provider-guided NAD+ injection protocols (dosage, frequency, cost) from telehealth and concierge clinics.
The honest finding: There is no FDA-approved NAD+ injection product and no standardized clinical dosing guideline. IV case reports range from 500–1,500 mg per session; IM/SubQ clinic protocols often start at 25–50 mg and may increase to 100 mg, dosed once or twice weekly.
Biggest advantage: A supervised provider can screen for contraindications, source from licensed compounding pharmacies, and adjust dosing based on your response.
Biggest limitation: You are paying for an unproven therapy. Evidence in humans is thin, and safety depends almost entirely on the provider and pharmacy.
Who may consider it: Adults who understand the regulatory gap, have no contraindications, and want physician oversight rather than gray-market self-injection.
Verify before buying: Screening process, pharmacy licensing and batch testing, total monthly cost, and refund/cancellation policy.
- What NAD+ Actually Is (and What It Isn’t)
- Why “Dosage” Is the Wrong Question to Start With
- What Supervised Protocols Actually Look Like
- Cost Comparison: What You Pay and What You Get
- Safety and Sourcing: The Part Marketing Pages Skip
- How to Evaluate a Provider (Practical Checklist)
- FAQs
- Final Verdict
- Disclosure, Disclaimer, and References
Introduction
You typed “best NAD+ injection dosage and frequency” into a search bar because you are trying to make a decision. Maybe a clinic quoted you a protocol that felt aggressive. Maybe you found three different dosage charts online and none of them agree. Maybe you are simply trying to understand whether the injections are worth the money.
Here is the uncomfortable truth the marketing pages avoid: no regulatory body has approved NAD+ injections for any indication, and no clinical guideline standardizes how they should be dosed. What does exist is a growing market of provider-guided protocols—some cautious, some aggressive, and some operating in a gray zone.
This article does not give you a “best dose” because that would be fiction. Instead, it gives you a decision framework: what clinical experience suggests, what the limited evidence actually shows, how costs compare, and what to verify before you pay.
📌 Add GLP1Cynergy as a Preferred Source on Google
See more of our evidence-first health reporting in Google Search and Top Stories.
What NAD+ Actually Is (and What It Isn’t)
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It is involved in energy metabolism, DNA repair, and stress response. Your body makes it and recycles it. Levels tend to decline with age, which is the biological hook that wellness marketers use.
What it is not: an FDA-approved drug for anti-aging, chronic fatigue, addiction, or any other condition. Injectable NAD+ is a compounded preparation—a category that carries different (and weaker) regulatory oversight than approved medications.
Why this matters for dosage: When a drug is not approved, there is no official label, no official dose, and no official frequency. Every number you see online is either from a small study, a clinic’s internal protocol, or marketing copy.
Why “Dosage” Is the Wrong Question to Start With
Most dosage charts you find online skip the question that determines everything else: Is this injection going into a vein, a muscle, or under the skin?
| Route | Typical clinic-reported range | What the evidence says |
|---|---|---|
| IV infusion | 500–1,500 mg per session in limited case reports | Case reports only; no controlled trials for general wellness |
| IM (intramuscular) | 25–100 mg per injection, 1–2× weekly (anecdotal) | One small pilot (n=5) used 0.33–1.0 cc every third day |
| Subcutaneous (SubQ) | Often 50–100 mg, 2–3× weekly | No published dosing studies identified |
A 1,500 mg IV infusion and a 50 mg SubQ injection are not interchangeable “doses.” They have different pharmacokinetics, different side-effect profiles, and different costs. Any article that gives you a single number without the route is incomplete.
What Supervised Protocols Actually Look Like
A responsible provider-guided protocol typically follows a sequence that prioritizes screening and sourcing over speed.
Step 1: Medical evaluation. A 30–60 minute consultation reviewing history, medications, and goals. Contraindications include pregnancy, breastfeeding, active cancer or certain cancer histories, significant cardiovascular disease, and known hypersensitivity to NAD+ or excipients.
Step 2: Baseline labs (when indicated). Thyroid, liver, kidney, and metabolic markers. Not every provider does this. The ones who do are signaling a different standard of care.
Step 3: Conservative initiation. IM/SubQ protocols often start lower (25–50 mg) and titrate based on tolerability. IV protocols may start at a lower dose and slow the infusion rate to manage flushing and nausea.
Step 4: Ongoing adjustment. Follow-up access to the prescribing clinician for side-effect management and protocol changes.
💡 Compare Provider-Guided Options
If you are evaluating a supervised NAD+ protocol, start by checking the provider’s screening process and pharmacy sourcing.
Check Current Provider Details → Compare Available Protocols →Cost Comparison: What You Pay and What You Get
| Cost category | IV clinic | At-home IM/SubQ (provider-guided) |
|---|---|---|
| Per session | $200–$1,500 | $50–$150 per injection (compounding pharmacy source) |
| Monthly (typical frequency) | $2,000–$6,000+ | $200–$600 |
| Included services | In-clinic monitoring, IV supplies, staff time | Telehealth consult, prescription, self-injection training |
| Hidden costs | Travel, time off work, membership fees | Labs, follow-up visits, sharps disposal, shipping |
The math that matters: A $200 injection sounds cheaper than a $1,000 infusion until you realize you may need 8–12 injections per month. Always calculate monthly total cost, not per-session price.
Cost per milligram is another useful check. A 100 mg injection at $100 is $1/mg. A 500 mg infusion at $500 is also $1/mg. The route and supervision level—not the raw NAD+ amount—are what you are actually paying for.
Safety and Sourcing: The Part Marketing Pages Skip
The FDA has warned about IV clinics using drug products prepared in unsanitary conditions. In October 2025, a Class I recall of a compounded NAD+ injection was reported, involving elevated endotoxin levels and emergency room visits. A Class I recall is the most serious category—it means the product may cause serious harm or death.
What this means practically: The single most important safety variable is who made the vial. Ask:
- Is the compounding pharmacy 503A state-licensed or 503B FDA-registered?
- Does the pharmacy provide batch-specific certificates of analysis for purity, sterility, and endotoxin levels?
- Is the NAD+ third-party tested?
If the provider cannot answer these questions clearly, the dose is irrelevant. A contaminated vial at any dose is a bad protocol.
Common side effects with supervised use include nausea, flushing, headache, and injection-site soreness. These are often related to dose and infusion rate and tend to resolve within hours. Unsupervised use removes the safety net that catches these reactions.
How to Evaluate a Provider (Practical Checklist)
Use this before you enter payment information.
| Question to ask | Why it matters |
|---|---|
| “Who will review my medical history?” | A prescription without screening is a transaction, not care |
| “Which compounding pharmacy do you use, and what is its license type?” | Sourcing determines sterility and purity |
| “Can you share a certificate of analysis for the NAD+ batch?” | Batch testing is the only way to verify what is in the vial |
| “What is the starting dose, and how will we adjust it?” | Conservative initiation and titration are basic safety practices |
| “What is the total monthly cost including labs and follow-up?” | Per-injection pricing hides recurring costs |
| “What happens if I have a side effect?” | Direct clinician access is a core part of supervision |
FAQs
Q: What is the “best” NAD+ injection dosage?
There is no single best dose because there is no standardized clinical guideline. Supervised protocols vary by route, provider, and patient. IV case reports have used 500–1,500 mg per session; IM/SubQ clinic protocols often start at 25–50 mg and may go up to 100 mg, dosed 1–2× weekly. The appropriate dose for you is a clinical judgment, not a search result.
Q: How often should NAD+ injections be given?
Frequency depends on the protocol and your response. Some IM pilot data used every-third-day dosing over 3–6 months. Some IV case reports used loading periods followed by maintenance every 4–6 weeks. A supervised provider will adjust frequency based on tolerability and goals.
Q: Are NAD+ injections FDA-approved?
No. There is no FDA-approved injectable NAD+ product for clinical use in the United States. Compounded NAD+ is not the same as an approved drug. This is why provider oversight and pharmacy sourcing matter so much.
Q: Is at-home self-injection safe?
It can be, if a licensed provider has screened you, prescribed a specific protocol, taught you injection technique, and sources from a licensed compounding pharmacy with batch testing. It is not safe if you are buying “research-only” vials online without medical oversight.
Q: What does NAD+ injection therapy cost per month?
At-home IM/SubQ protocols typically run $200–$600 per month depending on dose and frequency. Clinic IV therapy can run $2,000–$6,000+ monthly. Always ask for the total monthly cost including labs, shipping, and follow-up.
Final Verdict
There is no “best” NAD+ injection dosage in the sense of a proven, standardized number. The honest recommendation is a process, not a prescription:
- Start with a provider who screens you before prescribing. No screening, no injection.
- Ask for the pharmacy’s license type and a batch certificate of analysis. If they cannot provide it, walk away.
- Start conservative. A lower starting dose with titration is more defensible than a high-dose protocol from day one.
- Calculate monthly cost, not per-injection price. Include labs, follow-up, and shipping.
- Understand the evidence gap. You are paying for supervision and sourcing, not for a guaranteed anti-aging outcome.
If you are comfortable with that framework and want to compare supervised options, use the button below. If you are looking for a guaranteed result or a single “correct” dose, this is not the right therapy for you right now.
Review Supervised NAD+ Provider Options →📬 Subscribe for More Evidence-First Health Content
Get practical, myth-free guides on peptides, GLP-1 therapies, and wellness protocols—delivered without the hype.
Subscribe to the GLP1Cynergy Newsletter →Affiliate Disclosure
This article may contain affiliate links. If you click a link and make a purchase or initiate a service, we may earn a commission at no additional cost to you. Affiliate relationships do not determine which providers we discuss or what safety concerns we raise. We do not accept payment to suppress information about recalls, contraindications, or evidence gaps. The HerbsPro affiliate link and other sponsored links are disclosed here in accordance with FTC endorsement guidelines.
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. NAD+ injections are not FDA-approved for any indication. Always consult a licensed healthcare professional before starting, stopping, or changing any injectable therapy. Do not use gray-market or “research-only” NAD+ products for human injection. If you experience chest pain, severe dizziness, or signs of infection after an injection, seek medical attention immediately.
Reviewed by: Dr. Mohammed Abdul Azeem Siddiqui, MBBS, M.Tech, Director, Cosmo Hospital
References
- Verywell Health. “Is NAD+ a Miracle Anti-Aging Treatment, or Is It Just Hype?” February 2025.
- Fagron Academy. “Nicotinamide Adenine Dinucleotide (NAD+): A Review on Dosing.” June 2025.
- PraxisMed. “NAD+ Injectable Administration: Safety and Regulatory Status.” September 2025.
- Regenerated.Health. “NAD Injections: Benefits, Side Effects, What to Expect.” February 2026.
- Mirror Plastic Surgery. “Where to Get Supervised NAD+ Injections Safely.” September 2026.
- Nova Southeastern University. “Intramuscular NAD+ Therapy and Neuroenergetic Symptom Modulation: An Exploratory Retrospective Human Pilot Study.” 2026.
- Pure Peptide Clinic. “NAD injections: the complete guide (2026).” June 2026.
- Search Engine Journal. “How To Add Google’s Preferred Sources Button To Your Website.” August 2026.
